On the other hand, in prostate cancer cell lines, higher levels of PTX-3 were expressed by non-bone metastatic cells, probably due to more frequent osteoblastic cellular activity rather than osteolytic activity (encountered in breast cancer cell lines) [44,54]. Here, PTX3 is linked to prostate carcinoma.